Patients with multiple sclerosis (MS) may have twice the mortality risk compared to those without MS, despite research indicating that MS survival may be improving over time. The results from this study were published in the journal Neurology.
The National Association of Boards of Pharmacy (NABP) announced that the general availability for the .pharmacy domain will begin on June 3, 2015 for pharmacies and pharmacy-related entities.
Excessive inflammation that is present in multiple sclerosis (MS) may be due to a malfunctioning "brake" within immune cells to control the inflammation, researchers have concluded.
A study published in The BMJ suggests a link between newer contraceptive pills and higher risk of serious blood clots. The finding is not new, but it may be cause for a different kind of concern.
Study shows it helped a minority of patients, and experts say this approach has promise
Fine-motor and social skills slightly improved in boys, but no difference in IQ, researchers say
Researchers found greater risk of hip, other fractures
Research seems to question current recommendations regarding alcohol consumption
But CDC survey finds one-third continue the practice, which can undermine breastfeeding efforts
Study suggests improved coping for those whose loved ones had end-of-life care
- McDonald's and the Microbiome: What Effect Does Junk Food Have on Gut Bacteria?
- When the Doctor is Depressed: One Clinician Tells His Story
- Most Distinctive Causes of Death Mapped by U.S. State
- Spice + Statin Likely Culprit in Patient with Acute Hepatitis
- First Non-Surgical Tx for "Double Chin" Gains FDA Approval
- Comorbidities May Significantly Up Mortality Risk in MS Patients
- An Approach to Consider for Type 2 Diabetes Therapy Starts Here
- Treating Beta-Blocker Overdose When First-Line Therapies Fail
- NABP Hopes .Pharmacy Domain Will Help Weed Out Illegal Online Pharmacies
- Gene Mutation in MS Sheds Light on Movement, Balance Disorders